Chairman & CEO Howard W. Lutnick Announces Chemotherapy Treatments Completed

Chairman and CEO Howard W. Lutnick announced he completed his final chemotherapy treatment for Non-Hodgkin’s Lymphoma. Throughout his treatments, he remained resilient, continuing business as usual, motivated by the support of his employees. He reflected on Cantor, BGC, and Newmark and the path ahead for 2022.

[@batescp1]

First of all, as an outside observer from Tennessee, I have immense respect for you. The way you recovered the company and provided for the families after 9/11 is incredible. Secondly, as a message from the CEO, how does this video only have 126 views? This man deserves millions!

[@garrisonefird3002]

We’re with you indeed.